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Bioactive glasses/ceramics, such as Bioglass1, which was
developed by Hench and Lacefield, are potential materials for
bone regeneration and dental applications.[1] Bioactive glass
devices implanted at the site of bone defects can directly bond
to surrounding tissues by chemical linkage without the
formation of a fibrous transitional layer. Compared with
hydroxyapatite (HA), bioactive glasses/ceramics exhibit a
much higher biomineralization capability in vitro, being able
to rapidly induce the formation of apatite between the
bioactive glass ceramic and a simulated body fluid (SBF). This
process involves a complicated ion exchange mechanism
between the bioactive glasses and the SBF.[2] In the last five
years, a growing consensus has been reached to concentrate
on the development of nano-structural bioactive glasses/
ceramics materials due to their high biomineralization
capability.[3] Bioactive glass/ceramic nanoparticles can be
used as strengthening filler in the production of polymer-
inorganic nanocomposites.[4] It has also been reported that
needle-like or short-fiber inorganic particles can improve the
mechanical performance of polymer-inorganic composites
much more effectively than spherical fillers.[5] Therefore, an
interesting and promising area is the fabrication of nanopar-
ticles with high length-diameter ratios, such as needle-like or
rice-shaped particles.
In a previous work, needle-like HA particles have been
produced by a coprecipitation method;[6] it was shown that
such particles could drastically strengthen the mechanical
property of polymer composites. HA has been extensively
investigated for several decades, and has been widely applied
in bone tissue engineering, general orthopedic applications
and clinical dentistry.[7] Bulk HA-based materials can be
molded into different shapes to produce implantable devices.
HA particles, including nanoparticles, have also been
extensively studied. HAparticles can be imbedded in polymer
matrixes to produce strengthened osteo-conductive porous
scaffolds[8] or compact structures for bone fixation.[9] Being
the main inorganic component of natural bone, HA exhibits
excellent biocompatibility and promotes the attachment and
spreading of osteoblasts. However, the ability of HA to induce
the formation of an apatite layer on its surface when dipped in
simulated body solution (SBF) is relatively low.[10] It has been
reported that the incorporation of a small quantity of silicon in
the HA lattice can enhance the bioactivity of HA.[11] It has also
been reported that the presence of silicon may significantly
increase the activity of osteoblast-like cells.[12] In vivo testing
has also shown a positive result for a silicon-substitute HA
(Si-HA) material.[13] Compared with HA ceramics, Si-HA
exhibits a remarkably improved new bone formation
capability.
The main objective of this study was to synthesize
needle-like or rice-shaped bioactive ceramic (BAC) nanopar-
ticles. These were formulated with an unusually low silicon
content and a relatively high phosphorus concentration,
similar to Si-HAmaterials. This system may thus combine the
advantages of both hydroxyapatite and bioactive glasses,
enhancing its potential applicability in regeneration strategies
for mineralized tissues or more conventional medical
applications. Such nanoparticles can be mixed with some
bridgeable polymers to develop new biomaterials with
improved mechanical properties and adequate bioactivity.
Experimental
Materials
Tetraethoxysilane [TEOS; Si(OC2H5)4, Mw: 208.33, 99.99%],
calcium nitrate [Ca(NO3)2 ! 4H2O, Mw: 236.33, 99%], ammo-
nium dibasic phosphate [(NH4)2HPO4, Mw: 132.06, 98%] and
citric acid (C6H8O7, Mw: 192.123) were obtained from
Sigma-Aldrich. Poly(ethylene glycol) (PEG, Mn:
16 000–24 000) was bought from Fluka. Chitosan (high
molecular weight) was also purchased from Sigma-Aldrich,
and purified prior to use. All chemicals for polymer
purification and preparation of the membrane and the SBF
were obtained from Sigma-Aldrich, Germany and used
without further purification.
Preparation of Bioactive Ceramic Nano-particles Based on
SiO2-CaO-P2O5
BAC [SiO2/CaO/P2O5" 6:74:20 (mol)] nanoparticles were
prepared using a method based on a procedure previously
described.[4b,4c] Briefly, 11.936 g of Ca(NO3)2 and 0.9063mL of
TEOSwere dispersed in amixture of 60mL of deionizedwater
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and 30mL of ethanol. The pH of the solution was regulated to
approximately 2 by adding citric acid, with stirring. After
becoming transparent, this solution was dropped into 700mL
of deionized water containing 3.642 g of (NH4)2HPO4, with
vigorous stirring. During this procedure, the pH of the
solution was maintained at approximately 11 by successive
addition of an ammonium hydroxide solution. The suspen-
sion was stirred at ambient temperature for 24 h, and the
precipitate was separated from the reaction mixture by
centrifugation at 25 000 rpm, and washed 3 times with
deionized water. Then, the white precipitate was suspended
in a 2% (w/v) poly(ethylene glycol) solution. The precipitate
coated with PEG was freeze-dried (Freezone1 6L Benchtop
Freeze Dry System 7752020, Labconco) at #80 8C and
calcinated at 700 8C to obtain the final white BAC nanopar-
ticles.
Field Emission Scanning Electron Microscopy (FESEM)
The morphology of the bioactive nanoparticles was
observed using FESEM (XL30 FESEM FEG, Philips) equipped
with an energy–dispersive X-ray spectrum (EDS). This
microscope was a field emission SEM that allows low-voltage
operation and high-resolution observation. The size distribu-
tion of nanopowder was calculated from the FESEM images of
nanoparticles. The quantitative composition of ceramic
powder was roughly assessed by the relative intensity of
each element peaks in EDS curve. To avoid the effect of
substrate, BAC nanopowder was compressed to 1mm thick
pellets for EDS measurement.
Transmission Electronic Microscope
TEM (JEOL JEM-1011) was used to observe the size and
shape of the BAC particles. A typical TEM specimen was
prepared by putting a drop of 0.1% (w/v) BAC-water-ethanol
suspension onto a carbon-coated copper grid and drying at
room temperature in a desiccator.
FTIR Spectroscopic Analysis
A Bio-Rad Win-IR spectrometer was employed for FTIR
spectroscopic analysis. The BAC samples were mixed with
KBr powder and pressed into a disk suitable for FTIR
measurement. The FTIR spectra were recorded from 4 000 to
400 cm#1.
X-ray Diffraction (XRD)
XRD analysis was performed on a X-ray diffractometer
(Philips PW 1710, Netherlands) with a Cu-Ka radiation
(l¼ 0.154 nm) at 40 kV and 50mA. Data were collected from
2u¼ 10 to 608with a step size of 0.028. The crystallinity of BAC
nanopowder was assessed using the JAD-5 crystalline
analysis program.
Chitosan/BAC Membrane Preparation
Chitosan membranes and chitosan membranes containing
BAC were prepared by solvent-casting. Acetic acid 2% (w/w)
was used to dissolve the polymer to a final concentration of
1% (w/v). The chitosan solution was agitated constantly for
1 day and filtered to remove impurities. For the composite
membranes, a given quantity of nanoparticles (20wt.-%) was
added to the polymer solution. Thismixturewas stirred for 2 h
and then sonicated for 15min. The final solution was poured
into plastic Petri dishes (120% 120 mm2) and left to dry at
room temperature for 10 days. After drying, the prepared
composite membranes were neutralised in 0.1 M sodium
hydroxide solution for 10min, washed several times with
distilled water and left to dry at room temperature for 1 day.
Chitosan membranes without the inorganic component were
also prepared to be used as a control.
In Vitro Bioactivity Test
For the in vitro bioactivity tests, an acellular 1.0% SBF was
prepared in accordance with the formulation described by
Kokubo and co-workers [14]. Samplemembranes of 20% 15mm2
were cut from the original processed films for the bioactivity
tests. Three replicates for each sample were immersed in SBF
for 7 days at 37 8C. After being removed from the SBF, the
sample membranes were gently rinsed with distilled water
and dried at room temperature.
Scanning Electron Microscopy (SEM)
The morphological analysis of these membranes was
performed using SEM (Leica Cambridge S 360) at an
accelerated voltage of 15 kV. Before being observed by
SEM, the membranes were gold coated using a Hitachi
coating unit IB-2 coater at 6mA. The Ca and P elements were
identified by energy dispersive spectroscopy (EDS, Oxford
Link eXLII); for this elemental characterization the mem-
branes had to be carbon coated.
Results and Discussion
Morphology and Composition of BAC Nanoparticles
Figure 1a and b show a representative FESEM image and
the corresponding EDS curve of BAC nanoparticles prepared
in this work. Most of the particles exhibit a rice-like shape and
a very rough surface, which results from the assembly of
20 nm sized spherical nanoparticles. Such a coarse surface
tends to increase the specific surface area of the BAC powder.
Mixed with biodegradable or biocompatible polymers, it
could provide a more reactive and adsorptive interface
between the polymer component and the BAC filler. The EDS
curve indicates the existence of a small amount of carbon and
silicon in the BAC nanoparticles.
The approximate composition of BAC taken from the curve
is SiO2/CaO/P2O5" 6.3:71:22.7 (mol), which is a slight
deviation from the precursors formulation of Si/Ca/
P2O5" 6:74:20 (mol). The content of calcium was lower than
in the initial reaction mixture, which mainly resulted from the
removal of free Ca2þ that was not fully incorporated in the
silica or phosphoric gel network during the washing
procedure. In this kind of BAC nanoparticles, the ratio of
Ca to P was 1.564, which is lower than stoichiometric HA in
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the composition of natural bone; therefore, it is a calcium-
deficient material.
Figure 2a shows the excellent dispersibility of the BAC
nanoparticles, indicating that the system may be effectively
suspended in water-ethanol mixtures. Generally, the agglom-
eration of nanoparticles takes place in the step of condensation
or drying of gel particles. In order to avoid the aggregation of
nanoparticles, an extremely diluted reaction solution was
used for condensation of gel particle, and subsequently
subjected to lyophilization for drying of gel particles.
A TEM image of the BAC nanopowder is
shown in Figure 2b. A mesoporous structure
can be seen by examining the image of a
single particle. In terms of mechanism, our
hypothesis is under freezing, gel particles can
maintain their initial shape and size, result-
ing in phase separation between calcium
phosphate-silicate gel network and the
water-ethanol solution absorbed in the gel
particles. Furthermore, during lyophilization
the gel network cannot shrink along with the
extraction of water and ethanol. Therefore,
after drying and calcination, some nanome-
tric-size voids are formed in regions previously occupied by
water, ethanol, and organic precursors. This mesoporous
structure would increase the specific surface area of BAC
nanopowder and could possibly stimulate the biomineraliza-
tion process.[3d,6]
Before being subjected to lyophilization, gel particles were
enveloped with a compact PEG thin coating by strong
hydrogen bonds formed between the surface hydroxyls of
the gel particles and the surfactant molecules. PEG surfactant
may effectively reduce the interparticle collision that can
result in the interaction of surface hydroxyl of
gel particles and aggregation of BAC nano-
particles.
The size distribution of the BAC nano-
particles is quite narrow, as shown in
Figure 3. Most of the particles are around
70nm in diameter and 215nm in length. The
length/diameter ratio mostly ranges
between 2.3 and 3.8. The presence of silicon
in the formulation did not change the growth
tendency of HA particles along the C-axis.
The morphology of the new BAC nanopar-
ticles is similar to HA nanoparticles prepared
previously by a coprecipitation route.[6] If
incorporated into polymer matrixes, such
anisotropic nanoparticles could effectively
strengthen the composite material, compared
to spherical fillers.
XRD and FTIR
The XRD curves of both BAC and HA
particles exhibit similar characteristics, with
the typical HAdiffraction peaks being seen at
2u¼ 26 and 328 in both cases (see Figure 4).
However, the reflections for BAC are broader
than those of HA and some small crystalline
peaks disappeared in the BAC’s XRDpattern.
With the introduction of the silicon compo-
nent, crystallinity was slightly decreased to
approximately 95%, as estimated by JAD-5
analysis from the XRD curve. This indicates
that the silicon component imbedded in the
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Fig. 2. a) FESEM image of BAC nanoparticles dispersed in ethanol-water solution. b) TEM image of BAC
nanoparticles; the bar is 100 nm.
Fig. 1. a) FESEM image and b) EDX curve of the prepared BAC powder. SiO2/CaO/P2O5" 6.3:71:22.7 (mol);
Ca: P" 1.564 (mol).
Fig. 3. Size distribution of BAC nanoparticle powder: a) diameter, b) length, and, c) length to diameter ratio.
Solid curves are Gaussian fits to the histograms.
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phosphate lattice disturbed the crystallization, when com-
pared with HA.
The changes in the XRD pattern could be attributed to the
formation of hydroxyl vacancies, resulting from the substitu-
tion of phosphates by silicates. The differences could be also
ascribed to the change in the crystal sizes. Some researchers
believe that, in this kind of ceramic material, silicon is not
incorporated in the calcium phosphate gel network to
substitute the phosphorous in the gel structure.[13,15] In the
sol-gel process, the silicon precursor might be hydrolyzed to a
silica gel and calcined to a silicon dioxide phase in the final
ceramic particle. Another possibility is that hydrolyzed silicon
sol might have coprecipitated with calcium ions to form a
calcium silicate minor phase, which coexisted with the major
phase of phosphate.
The FTIR spectrum of the BAC particles is presented in
Figure 5a. The typical FTIR spectrum of HA powder is also
given here for comparison. Thewide absorption bands at 3 433
and 1 630 cm#1 should be assigned to the stretching vibration
of the H–O bond of a small quantity of H2O that was absorbed
in the ceramic powders. The intense stretching vibration band
of PO4
3# appears at 1 093, 1 037 and 960 cm#1. The sharp
double peaks at 601 and 564 cm#1 correspond to the O–P–O n4
bending mode. The small peak at 625 cm#1 was associated
with the liberation mode of O–H.[16] The stretching vibration
band of Si–O should appear between 1 100 and 1 000 cm#1, but
it was overlapped by the stretching vibration band of P–O. It
should also be noted that the carbonate absorption bands at
1 446, 1 414, and 875 cm#1 appeared in both spectra. The
carbonate existing in the lattice of the BAC powders could be
the result of the dissolution of CO2 from the atmosphere
during the sol-gel procedure. The assignment of the peak at
875 cm#1 is not straightforward. Some researcher attributed it
to the HPO4
2# group,[17] while it was also identified as the n3
Si–O stretching band in the silicate lattice.[18]
Figure 5b extends the FTIR spectra between 800 and
1 000 cm#1. A new absorption band is observed at 925 cm#1,
which has been considered as evidence of the incorporation of
silicon in the phosphate structure.[17b,19] The slight increase in
the 875 cm#1 peak should be attributed to the overlapping of
the silicate, phosphate, and carbonate bands.
In Vitro Bioactivity Test
The results of the bioactivity test obtained in both chitosan
and chitosan/inorganic composite membranes were evalu-
ated using SEM and EDS. After an immersion period of 7 days
in SBF at 37 8C, the SEM results in the composite membrane
showed the presence of an apatite layer with a cauliflower-like
morphology resulting from the assembly of nano-size needle-
like ceramic crystals (Figure 6a). This precipitate consisted of
the typical bone-like apatite coating that is produced onto
osteoconductive materials upon in vitro bioactivity tests. The
EDS test confirms the presence of calcium and phosphorous in
this ceramic layer (Figure 6b). As expected, no apatite was
formed in the unfilled chitosan membranes, as shown in the
SEM image and EDS curve (Figure 6c and d, respectively) of
pure chitosan film.
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Fig. 4. XRD pattern of the BAC powder and HA powder. (HA powder was prepared by
the sol-gel method with Ca(NO3)2 and (NH3)2HNO3 under alkaline condition.)
Fig. 5. a) FTIR spectrum of the BAC powder between 400 and 4 000 cm#1. b) Extended
FTIR spectrum of BAC nanoparticles between 800 and 1 000 cm#1. The FTIR spectrum
of HA is shown for comparison.
Fig. 6. a) SEM image of the apatite layer formed on the chitosan/BAC composite
membrane after 7 days of immersion in SBF, and, b) corresponding EDS results obtained
from analysis of the same sample. c) SEM image, and, d) EDS curve of neat chitosan film
after 7 days of immersion in SBF, shown for comparison. The bar is 5mm
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Conclusions
New rice-shaped or claviform low-silicon-content biocera-
mic nanoparticles were produced by an improved sol-gel
method, with sizes of about 70 nm in diameter and 210nm in
length. Calcination at 700 8C did not destroy the global
protuberances on the surface of the nanoparticles. Such a
coarse texture can improve the specific surface area of
nano-particles, facilitate the resolvability of the BAC material
and, consequently, increasing its bioactivity. If combined with
biocompatible polymers, the rough surface of the nanofiller,
combined with its anisotropy, would favor an increase in the
strength of the composite material. In vitro bioactivity tests
showed that these novel bioactive nanoparticles, containing
small quantity of silicon, have excellent biomineralization
capability. The results of this study suggest that such new
nanoparticulate systems could find applications in orthope-
dic-replacement-based strategies or be introduced in scaffolds
for bone tissue engineering.
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